Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 437,531 | 2,789,059 | 2,127,300 | 1,389,762 | 647,303 |
| Depreciation Amortization | 66,167 | 302,232 | 228,807 | 155,806 | 80,914 |
| Income taxes - deferred | 51,385 | 64,061 | 43,415 | 40,008 | 20,546 |
| Accounts receivable | -196,531 | -375,736 | -221,393 | -221,966 | -107,876 |
| Accounts payable and accrued liabilities | 107,652 | 428,944 | 257,805 | 295,648 | 176,114 |
| Other Working Capital | -159,461 | 211,853 | 72,128 | 74,978 | 31,677 |
| Other Operating Activity | 146,226 | 218,597 | 152,841 | 29,561 | -28,136 |
| Operating Cash Flow | $452,969 | $3,639,010 | $2,660,903 | $1,763,797 | $820,542 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 56,719 | 4,310,357 | -156,089 | -140,058 | -64,406 |
| PPE Investments | -23,199 | -131,904 | -105,794 | -41,505 | -14,870 |
| Net Acquisitions | -10,751,640 | -588,608 | -588,608 | -588,608 | -221,105 |
| Purchase Of Investment | -25,000 | N/A | N/A | 0 | N/A |
| Investing Cash Flow | $-10,743,120 | $3,589,845 | $-850,491 | $-770,171 | $-300,381 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,144,733 | 4,696,850 | 987,370 | 987,370 | 987,370 |
| Debt Repayment | -350,612 | -687,697 | -651,606 | -651,554 | -1,533 |
| Common Stock Issued | 132,530 | 211,737 | 158,234 | 115,912 | 58,879 |
| Common Stock Repurchased | -20,770 | -2,383,132 | -2,156,830 | -1,272,862 | -548,699 |
| Other Financing Activity | -50,291 | -74,189 | -100,219 | -65,718 | -10,907 |
| Financing Cash Flow | $1,855,590 | $1,763,569 | $-1,763,051 | $-886,852 | $485,110 |
| Exchange Rate Effect | 2,722 | -16,526 | -45,881 | -108,874 | -77,172 |
| Beginning Cash Position | 9,883,777 | 907,879 | 907,879 | 907,879 | 907,879 |
| End Cash Position | 1,451,942 | 9,883,777 | 909,359 | 905,779 | 1,835,978 |
| Net Cash Flow | $-8,431,835 | $8,975,898 | $1,480 | $-2,100 | $928,099 |
| Free Cash Flow | |||||
| Operating Cash Flow | 452,969 | 3,639,010 | 2,660,903 | 1,763,797 | 820,542 |
| Capital Expenditure | -23,199 | -131,904 | -105,794 | -41,505 | -14,870 |
| Free Cash Flow | 429,770 | 3,507,106 | 2,555,109 | 1,722,292 | 805,672 |